Department of Anesthesiology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Anesthesiology and Critical Care Medicine Key Laboratory of Luzhou, Southwest Medical University, Luzhou, Sichuan, China.
Front Immunol. 2024 Jul 15;15:1421473. doi: 10.3389/fimmu.2024.1421473. eCollection 2024.
In 2005, Altuvia and colleagues were the first to identify the gene that encodes miR-451 in the human pituitary gland, located in chromosome region 17q11.2. Subsequent studies have confirmed that miR-451 regulates various immune cells, including T cells, B cells, microglia, macrophages, and neutrophils, thereby influencing disease progression. The range of immune-related diseases affected encompasses various cancers, lymphoblastic leukemia, and injuries to the lungs and spinal cord, among others. Moreover, miR-451 is produced by immune cells and can regulate both their own functions and those of other immune cells, thus creating a regulatory feedback loop. This article aims to comprehensively review the interactions between miR-451 and immune cells, clarify the regulatory roles of miR-451 within the immune system, and assess its potential as both a therapeutic target and a biomarker for immune-related diseases.
2005 年,Altuvia 及其同事首次在人类垂体中鉴定出编码 miR-451 的基因,该基因位于 17q11.2 染色体区域。随后的研究证实,miR-451 调节各种免疫细胞,包括 T 细胞、B 细胞、小胶质细胞、巨噬细胞和中性粒细胞,从而影响疾病的进展。受影响的免疫相关疾病范围包括各种癌症、淋巴母细胞性白血病以及肺部和脊髓损伤等。此外,miR-451 由免疫细胞产生,可调节自身功能和其他免疫细胞的功能,从而形成调节反馈环。本文旨在全面综述 miR-451 与免疫细胞之间的相互作用,阐明 miR-451 在免疫系统中的调节作用,并评估其作为免疫相关疾病的治疗靶点和生物标志物的潜力。